MGP — Medica Share Price
Last trade - 00:00- £266.88m
- £267.05m
- £76.98m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.84 | ||
| PEG Ratio (f) | 0.77 | ||
| EPS Growth (f) | 32.67% | ||
| Dividend Yield (f) | 1.57% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.37 | ||
| Price to Tang. Book | 30.38 | ||
| Price to Free Cashflow | 45.75 | ||
| Price to Sales | 3.47 | ||
| EV to EBITDA | 19.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.25% | ||
| Return on Equity | 12.41% | ||
| Operating Margin | 10.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 38.97 | 46.54 | 36.81 | 61.91 | 76.98 | 85.74 | 95.03 | 17.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +22.4 | +8.78 | -72.17 | +138.53 | +30.48 | +62.66 | +15.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medica Group PLC is an international provider of telemedicine services. The Company’s principal activity is the provision of teleradiology reporting. Its network of consultant radiologists, radiographers and specialist doctors interpret and report magnetic resonance imaging (MRI), computerized tomography (CT), ultrasound and X-ray images on behalf of healthcare providers, using the Company’s technology platform for fast and responsive delivery. The Company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting. In Ireland, it carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening program for the national screening service. Through its United States business, RadMD, it provides global pharmaceutical and biotech companies, as well as contract research organizations with specialist imaging services for clinical trials.
Directors
- Gordon Davis NEC
- Stuart Quin CEO
- Richard Jones CFO
- Robert Lavis OTH
- Junaid Bajwa NID
- Joanne Easton NID
- Barbara Moorhouse NID (62)
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- April 22nd, 2013
- Public Since
- March 21st, 2017
- No. of Employees
- 212
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 126,483,063
- Address
- Sixth Floor, One Priory Square, HASTINGS, TN34 1EA
- Web
- https://medica.co.uk/
- Phone
- Auditors
- Grant Thornton UK LLP
Latest News for MGP
Upcoming Events for MGP
Half Year 2023 Medica Group PLC Earnings Release
Similar to MGP
Burning Rock Biotech
London Stock Exchange
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
IQ-AI
London Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in Medica are trading at 211.00p. This share price information is delayed by 15 minutes.
Shares in Medica last closed at 211.00p and the price had moved by +42.57% over the past 365 days. In terms of relative price strength the Medica share price has outperformed the FTSE All Share Index by +42.72% over the past year.
The overall consensus recommendation for Medica is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Medica dividend yield is 1.33% based on the trailing twelve month period.
Last year, Medica paid a total dividend of £0.03, and it currently has a trailing dividend yield of 1.33%.Looking ahead, the next dividend pay date is 2023-07-21.
We do not have data on when Medica is to next pay dividends. The historic dividend yield on Medica shares is currently 1.33%.
To buy shares in Medica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 211.00p, shares in Medica had a market capitalisation of £266.88m.
Here are the trading details for Medica:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MGP
Based on an overall assessment of its quality, value and momentum Medica is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medica is 208.00p. That is 1.42% below the last closing price of 211.00p.
Analysts covering Medica currently have a consensus Earnings Per Share (EPS) forecast of £0.10 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medica. Over the past six months, its share price has outperformed the FTSE All Share Index by +60.78%.
As of the last closing price of 211.00p, shares in Medica were trading +29.01% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medica PE ratio based on its reported earnings over the past 12 months is 18.84. The shares last closed at 211.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medica's management team is headed by:
- Gordon Davis - NEC
- Stuart Quin - CEO
- Richard Jones - CFO
- Robert Lavis - OTH
- Junaid Bajwa - NID
- Joanne Easton - NID
- Barbara Moorhouse - NID